Skip to main content
Log in

Spontaneous remission of methotrexateassociated lymphoproliferative disorder with Epstein-Barr virus type II latency

  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Liu X, Tang J, Wang M, Ma Q, Wang Y. Visual detection and evaluation of latent and lytic gene expression during Epstein–Barr virus infection using one–step reverse transcription loop–mediated isothermal amplification. Int J Mol Sci 2013; 14: 23922–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18: 1741–3.

    CAS  PubMed  Google Scholar 

  3. Gaulard P, Swerdlow SH, Harris L, Jaffe ES, Sundstrom C. Other iatrogenic immunodeficiency–associated lymphoproliferative disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Swerdlow SH, Campo E, Harris NL, et al. Lyon: IARC Press, 2008: 350–1.

    Google Scholar 

  4. Mariette X, Cazals–Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3–year prospective study in France. Blood 2002; 99: 3909–15.

    Article  CAS  PubMed  Google Scholar 

  5. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 2007; 34: 322–31.

    CAS  PubMed  Google Scholar 

  6. Kojima M, Itoh H, Hirabayashi K, et al. Methtrexate–associated lymphoproliferative disorders. a clinicopathological study of 13 Japanese cases. Pathol Res Pract 2006; 202: 679–85.

    Article  PubMed  Google Scholar 

  7. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 2013; 91: 20–8.

    Article  CAS  PubMed  Google Scholar 

  8. Terroso G, Aleixo J, Bernardes M, Mariz E, Fonseca E, Costa L. Nasal type extranodal NK/T cell lymphoma diagnosed in a patient with rheumatoid arthritis under methotrexate. Acta Reumatol Port 2014; 39: 77–81.

    CAS  PubMed  Google Scholar 

  9. Kondo S, Tanimoto K, Yamada K, et al. Mature T/NK–cell lymphoproliferative disease and Epstein–Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Virchows Arch 2013; 462: 399–407.

    Article  CAS  PubMed  Google Scholar 

  10. Yamakawa N, Fujimoto M, Kawabata D, et al. A clinical, pathological, and genetic characterization of methotrexate–associated lymphoproliferative disorders. J Rheumatol 2014; 41: 293–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasushi Matsuzaki.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuzaki, Y., Minakawa, S., Sagara, C. et al. Spontaneous remission of methotrexateassociated lymphoproliferative disorder with Epstein-Barr virus type II latency. Eur J Dermatol 28, 693–694 (2018). https://doi.org/10.1684/ejd.2018.3372

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3372

Navigation